Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
Liver function is a key factor that can help predict the clinical outcome in patients with
cirrhosis. Traditionally, liver function was measured using either indocyanine green (ICG) or
other radionucleotides. Recently, gadoxetic acid has been reported to show liver function in
several studies. There have been several approaches to measure liver function using gadoxetic
acid, and hepatocyte fraction is one of the promising methods. Since gadoxetic acid enhanced
liver MRI is clinically used world widely, it would be valuable if we can measure liver
function using hepatocyte fraction.